Pharmaceutical Biotechnology

What Pharmaceutical Biotechnology does

Pharmaceutical biotechnology s.r.o. is a Czech Republic-incorporated private limited company (s.r.o.) headquartered in Praha that develops and markets dietary supplements and modern nutritional preparations for end consumers ranging from children to post-productive age adults. The company states it focuses on biotech projects with high market potential and positions its products as supporting a responsible approach to health in modern, hectic lifestyles. Its product portfolio is manufactured under contract by partner Favea a.s. in pharmaceutical-licensed, GMP-certified facilities using innovative formulation technologies, with the company emphasizing R&D investment and high processing quality.

The business operates through a channel-partner GTM motion: Favea Plus acts as the exclusive distributor for Pharmaceutical biotechnology s.r.o. across four markets — Czech Republic, Slovakia, Poland, and Azerbaijan — with products sold through physical pharmacy chains and e-commerce platforms including eshop.faveaplus.cz, alza.cz, drmax.cz, benu.cz, and pilulka.cz. Revenue is generated through one-time product sales of dietary supplements (the company does not publicly disclose pricing). The firm is small (11-50 employees), has no disclosed revenue, has raised a single $83,347 EISMEA grant (June 2018), and shows no M&A, leadership changes, or AI/technology platform signals in the source data.

The customer model is horizontal and B2C, targeting general consumers across age segments through pharmacy retail and online channels. No enterprise or healthcare-anchor customers are named; the customer base is fragmented mass-market. The company's stated differentiators are GMP-certified manufacturing, proprietary/innovative formulation technology, and an exclusive regional distribution partnership, though it has no patents, trademarks, or AI capabilities disclosed in the input data.

Name

Pharmaceutical Biotechnology

Legal name

Pharmaceutical biotechnology s.r.o.

Website

https://pharmabiotech.cz

Company type

Private

Founded year

1928

Operating status

Operating

Headcount range

11–50 employees

Short description

Pharmaceutical biotechnology s.r.o. is a Czech dietary supplement manufacturer whose GMP-certified products are distributed exclusively by Favea Plus across Czech Republic, Slovakia, Poland, and Azerbaijan via pharmacies and e-commerce, serving general consumers from children to older adults.

Ownership category

akta.pro rank

Product category

Dietary Supplements

NAICS

Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)

Keywords

• Dietary supplements
• Nutritional supplements
• Pharmaceutical manufacturing
• Consumer health products
• Biotech products

Headquarters

HQ city

Praha

HQ country

Czechia

HQ region

Europe

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Dietary supplement product sales: The company manufactures and distributes dietary supplements and modern preparations designed to meet nutritional requirements of customers from children to post-productive age.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

Core offering

Pharmaceutical Biotechnology develops and distributes a portfolio of dietary supplements and modern nutritional preparations designed to meet the nutritional requirements of customers from children to post-productive age. Products are manufactured by partner Favea a.s. in GMP-certified pharmaceutical licensed facilities using innovative production technologies, and are sold under the company's own brand through pharmacies and e-commerce platforms across Central Europe and Azerbaijan.

Differentiator

Problem solved

Functional benefit

Products and services

• Dietary supplements portfolio

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• Favea PluscoreChannel Partner/ Reseller/ DistributorFavea Plus is the exclusive distributor of Pharmaceutical Biotechnology products. They handle distribution across Czech Republic, Slovakia, Poland, and Azerbaijan through pharmacies and e-commerce platforms.
• Favea a.s.coreStrategic or Co-development PartnerFavea a.s. manufactures products for Pharmaceutical Biotechnology. They utilize innovative technologies and focus on research and development of dietary supplements. Products are manufactured in pharmaceutical licensed facilities under GMP conditions.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Others

• Bayer Consumer Health:

Direct peers

• Walmark: Leading Central European dietary supplement brand headquartered in the Czech Republic. Directly comparable as a CEE-focused nutraceutical manufacturer-distributor selling through pharmacy chains and e-commerce across overlapping markets.

Broad incumbents

• Stada Arzneimittel: European generics and consumer healthcare group with a sizable nutraceutical/OTC portfolio. Comparable as a broad incumbent selling dietary supplements and OTC products across European pharmacy chains.
• Reckitt Benckiser (Health): Major consumer health company marketing supplement and self-care brands across Europe. Comparable as a broad incumbent in consumer health nutritional products sold through pharmacy retail.
• Perrigo Company: Global OTC and store-brand supplement manufacturer with extensive European presence. Comparable as a broad incumbent in consumer self-care nutritional products distributed through pharmacy and retail channels.
• Procter & Gamble Health: Global consumer health division marketing vitamins and OTC supplements across Europe. Comparable as a broad incumbent operating in the same consumer supplement category with established pharmacy distribution.

Regional players

• Generica: Czech pharmaceutical and dietary supplement distributor serving pharmacy chains in CZ/SK. Comparable as a regional pharmaceutical-channel supplement distributor operating in overlapping CEE markets.
• Zentiva: Major Czech-headquartered pharmaceutical company with branded generics and consumer health products distributed across CEE. Comparable as a CEE pharma manufacturer with GMP operations and pharmacy channel reach.

Emerging players

• Herbalife Nutrition: Global nutrition company selling dietary supplements through direct-selling and retail channels. Comparable as a multi-country dietary supplement seller with an asset-light distribution model.
• Now Foods: US-headquartered dietary supplement manufacturer with growing international e-commerce presence. Comparable as a GMP-manufacturing supplement producer building cross-border D2C and retail distribution.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmaceutical Biotechnology